Hepatobiliary system-liver and pancreas and gall bladder and ducts, percutaneous approach: códigos SUNAT

85813200 Hepatobiliary system-liver and pancreas and gall bladder and ducts, percutaneous approach

• 85813201Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, percutaneous approach
• 85813202Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, percutaneous approach
• 85813203Introduction of destructive agent into biliary and pancreatic tract, percutaneous approach
• 85813204Introduction of other gas into biliary and pancreatic tract, percutaneous approach
• 85813205Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, percutaneous approach
• 85813206Introduction of other diagnostic substance into biliary and pancreatic tract, percutaneous approach
• 85813207Introduction of radioactive substance into biliary and pancreatic tract, percutaneous approach
• 85813208Introduction of other therapeutic substance into biliary and pancreatic tract, percutaneous approach
• 85813209Introduction of local anesthetic into biliary and pancreatic tract, percutaneous approach
• 85813210Introduction of electrolytic and water balance substance into biliary and pancreatic tract, percutaneous approach
• 85813211Introduction of nutritional substance into biliary and pancreatic tract, percutaneous approach
• 85813212Introduction of anti-inflammatory into biliary and pancreatic tract, percutaneous approach
• 85813213Introduction of other anti-infective into biliary and pancreatic tract, percutaneous approach
• 85813214Introduction of oxazolidinones into biliary and pancreatic tract, percutaneous approach
• 85813215Introduction of monoclonal antibody into biliary and pancreatic tract, percutaneous approach
• 85813216Introduction of other antineoplastic into biliary and pancreatic tract, percutaneous approach
• 85813217Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, percutaneous approach